A Very Lazy Imatinib's Approach To Be Successful

73 m2 as the primary outcome measure. Median age at LT was 2.2 years. Primary diagnoses were biliary atresia (44.6%), fulminant liver failure (9.8%), metabolic liver disease (16.4%), chronic cholestatic liver disease (13.1%), cryptogenic cirrhosis (4.3%) and other (11.8%). At a mean of 5.2 years post-LT, 17.6% of patients had a mGFR http://www.selleck.cn/products/mi-773-sar405838.html analysis, factors associated with this outcome were transplant center, age at LT, primary diagnosis, calculated GFR (cGFR) at LT and 12 months post-LT, primary immunosuppression, early post-LT kidney complications, age at mGFR, height and weight Z-scores at 12 months post-LT. In multivariate analysis, independent variables associated with a mGFR http://www.selleckchem.com/products/Imatinib-Mesylate.html (1�C10). In LT recipients in particular, the risk of chronic kidney disease in adults is up to 18% by 13 years posttransplant (11). The morbidity and mortality of this complication in pediatric transplant recipients are potentially greater than those described in adults, as children have a longer life span following transplantation with greater cumulative exposure to the calcineurin inhibitors and other nephrotoxic drugs (12�C14). In addition, the impact on kidney function of physiologic changes associated with pubertal growth and development in this population is unknown. These changes may accelerate the progression of calcineurin inhibitor induced nephrotoxicity as has been noted in other chronic nephropathies (15�C18). One of the goals of long-term posttransplant management is to prevent or delay the onset of late complications, such as chronic http://www.selleckchem.com/products/VX-770.html kidney dysfunction. In order to accomplish this goal, we must identify those at risk, define contributing factors, and develop strategies for intervention. A thorough examination of the clinical and biochemical risk factors, and the impact of proposed interventions in pediatric transplant patients has been hampered by the limitations and biases associated with small populations, single centers, and variable and insensitive outcome measures. This has resulted in conflicting reports regarding prevalence, risk factors, timing and progression of posttransplant kidney dysfunction in children (19�C28).